Mitchell William M's Form 4 filing
AIM ImmunoTech Inc. (AIM) · filed Apr 23, 2025
- Accession no.
- 0001641172-25-005862
- Filed
- Apr 23, 2025, 4:35 PM ET
- Trade date
- Apr 11, 2025
- Filing delay
- 12 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $5.00K. It was filed 12 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mitchell William MCIK 0001191434 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 11, 2025 | Common Stock | PPurchaseAcquired | +196,851 | $0.0254 | +$5,000.02 | 521,723 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.